Alterity Therapeutics (ATHE) Presents Positive Phase 2 Data for ATH434
Alterity Therapeutics Limited (NASDAQ:ATHE) is one of the best performing ASX stocks in 2025.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 20,077 | $71,474 | +20% | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 139,258 | $484,618 | 0.22% | |
| 2. | 58,460 | $203,441 | 0% | |
| 3. | 58,382 | $203,170 | 0% | |
| 4. | 32,000 | $111,360 | 0% | |
| 5. | 6,809 | $23,695 | 0% |